2-Chloro-4,6-di(naphthalen-2-yl)-1,3,5-triazine

Catalog No. :
ACTIME783
CAS No. :
1247124-77-1
Molecular Formula :
C23H14ClN3
Molecular Weight :
367.84

IUPAC Name:2-chloro-4,6-di(naphthalen-2-yl)-1,3,5-triazine

2-Chloro-4,6-di(naphthalen-2-yl)-1,3,5-triazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$121.00Login to see priceIn stockInquiry
100g97%$450.00Login to see priceInquiryInquiry
500g97%$1638.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-4,6-di(naphthalen-2-yl)-1,3,5-triazine
IUPAC Name2-chloro-4,6-di(naphthalen-2-yl)-1,3,5-triazine
MDL No.-
Molecular FormulaC23H14ClN3
Molecular Weight367.84
SMILESClC1=NC(C2=CC=C3C=CC=CC3=C2)=NC(C4=CC=C5C=CC=CC5=C4)=N1
InChI KeyCNJJVLLNTJDXEA-UHFFFAOYSA-N
Synonym2-Chloro-4,6-di(naphthalen-2-yl)-1,3,5-triazine | CS-0181014 | AMY37892 | SCHEMBL106959 | DTXSID20731662 | 1,3,5-Triazine, 2-chloro-4,6-di-2-naphthalenyl- | 2-Chloro-4,6-bis(naphthalene-2-yl)-1,3,5-triazine | 2-chloro-4,6-bis(naphthalen-2-yl)-1,3,5-triazi
CAS No.1247124-77-1
PubChem CID59365884

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTIME783 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUEAM185 route compound structure diagram
    ACUEAM18532316-92-0 In Stock
  4. Then
  5. ACTIME783 route product structure diagram
    ACTIME7831247124-77-1 In Stock
Inquiry

2. ACTIME783 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKYJE798 route compound structure diagram
    ACKYJE798580-13-2 In Stock
  2. Then
  3. ACTIME783 route product structure diagram
    ACTIME7831247124-77-1 In Stock
Inquiry

Comments (0)